Primary Site >> Liver Cancer

Gene >> MAP2K2

Journal: Mol Cancer Res. 2004 Mar;2(3):159-69.
Title: Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway.
Author: Yun, Chawon|Cho, Hyeseon|Kim, Su-Jeong|Lee, Jae-Ho|Park, Sun Yi|Chan, Gordon K|Cho, Hyeseong
PMID: 15037655
Journal: Arch Toxicol. 2012 Mar;86(3):497-507.
Title: Mechanistic study on liver tumor promoting effects of flutamide in rats.
Author: Tawfeeq, Mohammad Monir|Hayashi, Hitomi|Shimamoto, Keisuke|Suzuki, Kazuhiko|Shibutani, Makoto|Inokuma, Hisashi|Mitsumori, Kunitoshi
PMID: 22076107
Journal: Carcinogenesis. 2013 Jan;34(1):38-47.
Title: MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.
Author: Guegan, Jean-Philippe|Ezan, Frederic|Theret, Nathalie|Langouet, Sophie|Baffet, Georges
PMID: 23042098
Journal: Biomed Pharmacother. 2017 Feb;86:27-31.
Title: Contrary influence of clinically applied sorafenib concentrations among hepatocellular carcinoma patients.
Author: Lin, Zu-Yau|Chuang, Wan-Long
PMID: 27936391
Journal: J Mol Med (Berl). 2017 Nov;95(11):1237-1249.
Title: Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
Author: Lin, Bonan|Zhou, Xiaomeng|Lin, Shuye|Wang, Xiaoyue|Zhang, Meiying|Cao, Baoping|Dong, Yan|Yang, Shuai|Wang, Ji Ming|Guo, Mingzhou|Huang, Jiaqiang
PMID: 28844099
Journal: Cell Death Dis. 2018 May 1;9(5):482.
Title: The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
Author: Li, Wenjuan|Cui, Kaisa|Prochownik, Edward V|Li, Youjun
PMID: 29706623